Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (636)
  2. Journal Article (509)
  3. Review (142)
  4. Editorial (64)
  5. Research Letter (50)
  6. Correspondence (15)
  7. Guidelines (6)
  8. Book Section (3)
  9. Conference Paper (2)
  10. Miscellaneous (2)
Groups
  1. Department of Medicine (1165)
  2. Graduate Medical Education (1122)
  3. GME, Medicine (1098)
  4. Hematologic Malignancies, Division of (752)
  5. Weinberg Fellows (660)
  6. Solid Tumor Oncology Division (617)

More Groups

People
  1. Jan Bewersdorf (102)
  2. Maria Palomba (94)
  3. Zachary Epstein-Peterson (94)
  4. Gunjan Shah (93)
  5. Gilles Salles (89)
  6. Michael Scordo (87)

More People

Years
  1. 2025 (165)
  2. 2024 (357)
  3. 2023 (296)
  4. 2022 (222)
  5. 2021 (159)
  6. 2020 (114)

More Years

Publications
  1. Blood (288)
  2. Journal of Clinical Oncology (219)
  3. Clinical Cancer Research (38)
  4. Annals of Oncology (35)
  5. Cancer Research (35)
  6. Journal of Thoracic Oncology (31)

More Publications

Publishers
  1. American Society of Hematology (323)
  2. American Society of Clinical Oncology (251)
  3. Elsevier Inc. (143)
  4. Nature Publishing Group (107)
  5. American Association for Cancer Research (104)
  6. Oxford University Press (61)

More Publishers

Results (1429)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Devlin, S. M.; Valtis, Y. K.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E.; Liotta, K.; Yu, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Low target antigen expression mediates resistance to BCMA CAR T cell therapy
    Meeting Abstract

    Perica, K.; Nataraj, S.; Sjojstrand, M. L.; Nagel, K.; Pavkovic, E.; Payson, E.; Cuenca, A.; Patel, A.; Chung, D.; Mailankody, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Cassanello, G.; Rivas-Delgado, A.; Luna De Abia, A.; Corona, M.; Luttwak, E.; Okwali, M.; Isgor, I.; Galera, P.; Boardman, A. P.; Caron, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
    Research Letter

    Qualls, D. A.; Lambert, N.; Caimi, P. F.; Merrill, M.; Pullarkat, P.; Godby, R. C.; Bond, D. A.; Wehmeyer, G. T.; Romancik, J.; Amoozgar, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Synthetic dual-costimulation for TCR and TCR-like targeted cell therapies
    Meeting Abstract

    Dobrin, A.; Xie, H.; Perica, K.; Jain, N.; Sadelain, M.; Hamieh, M.
    Human Gene Therapy (2023)

    Fulltext@MSK | Save
  • Precision management of a patient with dihydropyrimidine dehydrogenase deficiency and liver-predominant metastatic rectal cancer using hepatic arterial floxuridine
    Journal Article

    Lumish, M.; Thackray, J.; Do, R. K. G.; Caudle, K. E.; Amstutz, U.; Schwab, M.; Diasio, R. B.; Jarnagin, W. R.; Cercek, A.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcomas
    Journal Article

    Rosenbaum, E.; Seier, K.; Bradic, M.; Kelly, C.; Movva, S.; Nacev, B. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • Aiming for the cure in myeloma: Putting our best foot forward
    Review

    Bar, N.; Firestone, R. S.; Usmani, S. Z.
    Blood Reviews (2023)

    Fulltext@MSK | Save